27 Jul 2017 | 8:25 PM
 

GlaxoSmithKline Consumer Healthcare Ltd. Share Price Live (BSE)
0

BSE Code: 500676 | NSE Symbol: GSKCONS
5,540.00
36.05
(0.66 %)
27 Jul 2017 | 03:41 PM
Change company
  • Open (Rs)
    5,481.40
  • Prev. close (Rs.)
    5,503.95
  • High (Rs.)
    5,554.00
  • Low (Rs.)
    5,481.40
  • 52W H (Rs.)
    6,488.00
  • 52W L (Rs.)
    4,650.00
  • Volume (Rs.)
    271
  • MCap (Rs in Cr.)
    23,299.03

GlaxoSmithKline Consumer Healthcare Ltd. Financial Information

No Data Found !!
Mar 2017 Mar 2016 Mar 2015 Mar 2014 Dec 2012 Dec 2011
Key Ratios
PER SHARE RATIOS
Adjusted E P S (Rs.) 156.15 163.34 138.77 160.44 103.85 84.46
Adjusted Cash EPS (Rs.) 171.41 176.99 153.53 175.31 112.43 95.39
Reported EPS (Rs.) 156.15 163.34 138.77 160.44 103.85 84.46
Reported Cash EPS (Rs.) 171.41 176.99 153.53 175.31 112.43 95.39
Dividend Per Share 70.00 70.00 55.00 45.00 45.00 35.00
Operating Profit Per Share (Rs.) 198.19 198.52 173.60 207.53 136.35 119.95
Book Value (Excl Rev Res) Per Share (Rs.) 198.19 198.52 173.60 207.53 136.35 119.95
Book Value (Incl Rev Res) Per Share (Rs.) 198.19 198.52 173.60 207.53 136.35 119.95
Net Operating Income Per Share (Rs.) 947.90 1,024.53 1,024.26 1,157.65 757.92 657.46
Free Reserves Per Share (Rs.) 0.00 0.00 0.00 0.00 0.00 0.00
PROFITABILITY RATIOS
Operating Margin (%) 20.90 19.37 16.94 17.92 17.98 18.24
Gross Profit Margin (%) 19.29 18.04 15.50 16.64 16.85 16.58
Net Profit Margin (%) 16.47 15.94 13.54 13.85 13.70 12.84
Adjusted Cash Margin (%) 17.04 16.22 14.25 14.52 14.32 14.07
Adjusted Return On Net Worth (%) 21.02 28.08 27.61 37.22 32.09 31.04
Reported Return On Net Worth (%) 21.02 28.08 27.61 37.22 32.09 31.04
Return On long Term Funds (%) 32.44 43.18 42.11 56.10 47.84 47.52
LEVERAGE RATIOS
Long Term Debt / Equity 0.00 0.00 0.00 0.00 0.00 0.00
Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00
Owners fund as % of total Source 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Assets Turnover Ratio 1.43 1.89 2.19 3.07 2.54 2.63
LIQUIDITY RATIOS
Current Ratio 2.40 1.93 1.83 1.90 1.81 1.85
Current Ratio (Inc. ST Loans) 2.40 1.93 1.83 1.90 1.81 1.85
Quick Ratio 2.08 1.65 1.53 1.59 1.45 1.41
Inventory Turnover Ratio 198.19 198.52 173.60 207.53 136.35 119.95
PAYOUT RATIOS
Dividend payout Ratio (Net Profit) 44.83 42.85 39.63 28.04 43.33 41.43
Dividend payout Ratio (Cash Profit) 40.83 39.54 35.82 25.66 40.02 36.69
Earning Retention Ratio 55.17 57.15 60.37 71.96 56.67 58.57
Cash Earnings Retention Ratio 59.17 60.46 64.18 74.34 59.98 63.31
COVERAGE RATIOS
Adjusted Cash Flow Time Total Debt 0.00 0.00 0.00 0.00 0.00 0.00
Financial Charges Coverage Ratio 387.79 1,406.27 1,284.88 1,026.01 283.58 170.12
Fin. Charges Cov.Ratio (Post Tax) 260.47 940.96 872.49 701.65 196.12 116.73
COMPONENT RATIOS
Material Cost Component(% earnings) 32.86 31.37 35.93 35.67 36.67 38.55
Selling Cost Component 0.00 0.00 0.00 0.00 0.00 0.00
Exports as percent of Total Sales 6.50 6.53 5.46 6.68 6.20 6.68
Import Comp. in Raw Mat. Consumed 3.31 2.66 2.73 3.11 2.60 2.10
Long term assets / Total Assets 1.43 1.89 2.19 3.07 2.54 2.63
Bonus Component In Equity Capital (%) 98.67 98.67 98.67 98.67 98.67 98.67
VALUATION RATIOS
Enterprise Value (Rs.Cr.) 20,226.37 20,601.48 21,017.22 21,474.96 21,849.50 22,234.09
EV / Net Sales (X) 5.07 4.78 4.88 4.41 6.85 8.04
EV / EBITDA (X) 18.77 18.50 22.08 19.89 31.80 37.70
MarketCap / Sales (X) 5.85 5.41 5.41 4.79 7.31 8.43
Retention Ratios (%) 55.17 57.15 60.37 71.96 56.67 58.57
Price / BV (X) 0.00 0.00 0.00 0.00 0.00 0.00
Price / Sales (X) 5.85 5.41 5.41 4.79 7.31 8.43
Earning Yield (%) 0.03 0.03 0.03 0.03 0.02 0.02
No Data Found !!
Rs in Cr Mar 2017 Mar 2016 Mar 2015 Mar 2014 Dec 2012 Dec 2011
SOURCES OF FUNDS
Owner's Fund
Equity Share Capital 42.06 42.06 42.06 42.06 42.06 42.06
Share Application Money 0.00 0.00 0.00 0.00 0.00 0.00
Preference Share Capital 0.00 0.00 0.00 0.00 0.00 0.00
Reserves and Surplus 3,080.61 2,403.58 2,070.98 1,770.79 1,318.92 1,102.12
Loan Funds
Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00
Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00
Total 3,122.67 2,445.63 2,113.04 1,812.85 1,360.98 1,144.17
USES OF FUNDS
Fixed Assets
Gross Block 630.30 1,025.82 986.64 783.48 589.82 570.25
Less : Revaluation Reserve 0.00 0.00 0.00 0.00 0.00 0.00
Less: Accum. Depreciation 142.87 539.85 494.90 443.57 395.99 369.56
Net Block 487.43 485.97 491.74 339.91 193.83 200.69
Capital Work in Progress 57.67 51.39 42.31 38.45 197.24 149.16
Investments 0.00 0.00 0.00 0.00 0.00 0.00
Net Current Assets
Current Assets, Loans and Advances 4,415.08 3,961.44 3,485.49 3,033.11 2,163.42 1,732.61
Less : Current Liabilities and Provisions 1,837.51 2,053.17 1,906.51 1,598.62 1,193.51 938.28
Total Net Current Assets 2,577.57 1,908.27 1,578.98 1,434.49 969.91 794.33
Miscellaneous expenses not written 0.00 0.00 0.00 0.00 0.00 0.00
Total 3,122.67 2,445.63 2,113.04 1,812.85 1,360.98 1,144.17
Note :
Book Value of Unquoted Investments 0.00 0.00 0.00 0.00 0.00 0.00
Market Value of Quoted Investments 0.00 0.00 0.00 0.00 0.00 0.00
Contingent liabilities 156.22 158.34 631.60 425.61 442.06 295.96
Number of Equity shares outstanding 4.21 4.21 4.21 4.21 4.21 4.21
No Data Found !!
Rs in Cr Mar 2017 Mar 2016 Mar 2015 Mar 2014 Dec 2012 Dec 2011
INCOME :
Sales Turnover 3,986.46 4,308.73 4,307.59 4,868.57 3,187.49 2,765.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00
Stock Adjustments -7.66 -2.70 -42.97 8.91 -14.47 -44.00
Total Income 3,978.80 4,306.03 4,264.62 4,877.48 3,173.02 2,721.00
EXPENDITURE :
Raw Materials 907.35 944.56 1,056.83 1,162.24 778.02 697.95
Excise Duty 434.63 409.55 223.44 275.91 179.48 146.59
Power and Fuel Cost 72.31 78.66 80.86 98.19 62.86 55.23
Other Manufacturing Expenses 72.31 78.66 80.86 98.19 62.86 55.23
Employee Cost 458.03 509.40 431.29 470.05 301.12 258.37
Selling and Administration Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Less: Preoperative Expenditure Capitalised 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenditures 1,944.63 2,020.82 1,873.29 2,104.59 1,384.34 1,213.36
Profit before Interest, Depreciation and Tax 633.07 1,026.61 987.38 784.53 592.24 573.71
Interest and Financial Charges 2.78 0.79 0.74 1.05 2.42 3.47
Profit before Depreciation and Tax 630.30 1,025.82 986.64 783.48 589.82 570.25
Depreciation 64.18 57.44 62.09 62.55 36.08 45.98
Profit Before Tax 1,010.42 1,055.40 889.14 1,016.07 648.69 540.26
Tax 353.74 368.48 305.54 341.33 211.93 185.05
Profit After Tax 656.68 686.91 583.60 674.75 436.76 355.21
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P and L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2,367.52 1,780.78 1,430.62 1,142.39 731.27 501.10
P and L Bal. carried down 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend 234.46 234.46 184.22 157.09 158.55 123.32
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Corporate Dividend Tax 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Earning Per Share (Rs.) 0.00 0.00 0.00 0.00 0.00 0.00
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
No Data Found !!
Rs in Cr Mar 2016 Mar 2015 Mar 2014 Dec 2012 Dec 2011 Dec 2010 Dec 2009
Cash and Cash Equivalents at Beginning of the year 925.38 205.38 54.99 53.38 35.90 819.80 470.98
Cash Flow From Operating Activities
Net Profit before Tax and Extraordinary Items 1,055.40 889.14 1,016.07 648.69 540.26 451.80 353.86
Adjustments :
Depreciation 0.00 0.00 0.00 0.00 0.00 39.71 42.02
Interest (Net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Received 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/L on Sales of Assets 0.00 0.00 0.00 0.00 0.00 -1.88 1.50
P/L on Sales of Invest 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Prov. and W/O (Net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/L in Forex 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fin. Lease and Rental Charges 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Adjustments (PBT and Extraordinary Items) 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Profit before Working Capital Changes 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Adjustments :
Trade and 0ther Receivables 0.00 0.00 0.00 0.00 0.00 -20.07 10.77
Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Trade Payables 0.00 0.00 0.00 0.00 0.00 133.45 141.38
Loans and Advances 0.00 0.00 0.00 0.00 0.00 -20.44 4.14
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Stock on Hire 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leased Assets Net of Sale 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Trade Bill(s) Purchased 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Change in Borrowing 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Change in Deposits 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Adjustments (OP before Working Capital Changes) 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Generated from/(used in) Operations 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Adjustments :
Interest Paid(Net) 0.00 0.00 0.00 0.00 0.00 2.60 4.27
Direct Taxes Paid 0.00 0.00 0.00 0.00 0.00 -159.70 -139.84
Advance Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Adjustments(Cash Generated from/(used in) Operations 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Flow before Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Extraordinary Items :
Excess Depreciation W/b 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premium on Lease of land 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payment Towards VRS 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Prior Year's Taxation 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gain on Forex Exch. Transactions 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash from Operating Activities 572.35 611.47 644.50 554.33 390.73 326.21 400.24
Cash Flow from Investing Activities
Investment in Assets :
Purchased of Fixed Assets 0.00 0.00 0.00 0.00 0.00 -114.30 -46.29
Sale of Fixed Assets 0.00 0.00 0.00 0.00 0.00 5.67 1.03
Capital WIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital Subsidy Received 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial / Capital Investment :
Purchase of Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Sale of Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investment Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest Received 0.00 0.00 0.00 0.00 0.00 29.24 23.69
Dividend Received 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Invest.In Subsidiaires 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Loans to Subsidiaires 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investment in Group Cos. 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Issue of Shares on Acquisition of Cos. 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cancellation of Investment in Cos. Acquired 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Acquisition of Companies 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inter Corporate Deposits 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash used in Investing Activities -156.88 330.69 -271.42 -377.24 -125.19 -79.39 -21.58
Cash Flow From Financing Activities
Proceeds :
Proceeds from Issue of shares (incl. share premium) 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Proceed from Issue of Debentures 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Proceed from 0ther Long Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Proceed from Bank Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Proceed from Short Tem Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Proceed from Deposits 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Application Money 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash/Capital Investment Subsidy 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Loans from a Corporate Body 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payments :
Share Application Money Refund 0.00 0.00 0.00 0.00 0.00 0.00 0.00
On Redemption of Debenture 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Of the Long Tem Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Of the Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Of Financial Liabilities 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Paid 0.00 0.00 0.00 0.00 0.00 -75.50 -24.82
Shelter Assistance Reserve 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest Paid 0.00 0.00 0.00 0.00 0.00 -2.45 -5.01
Others -279.19 -222.15 -222.70 -175.47 -248.06 -12.57 0.00
Net Cash used in Financing Activities -279.19 -222.15 -222.70 -175.47 -248.06 -90.52 -29.84
Net Inc./(Dec.) in Cash and Cash Equivalent 136.28 720.00 150.38 1.61 17.48 156.30 348.82
Cash and Cash Equivalents at End of the year 1,061.67 925.38 205.38 54.99 53.38 976.10 819.80
No Data Found !!
Rs in Cr Mar 2017 Dec 2016 Sep 2016 Jun 2016 Mar 2016 Dec 2015 Sep 2015
Sales 1,101.87 860.39 1,080.27 943.90 1,077.42 971.70 1,091.78
Other Income 70.96 55.92 57.82 59.18 50.07 57.58 58.90
Stock Adjustment 29.52 -21.64 22.13 -37.67 21.54 -74.73 38.80
Raw Material 299.72 257.62 304.44 288.97 300.00 346.43 300.23
Power And Fuel 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Employee Expenses 103.62 106.66 130.74 126.21 142.79 121.19 121.80
Excise 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Admin And Selling Expenses 173.52 92.42 127.19 121.55 155.30 125.04 146.60
Research And Devlopment Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses Capitalised 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Expenses 231.23 216.51 210.02 216.37 219.75 236.27 212.00
Provisions Made 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Profit 217.07 167.69 245.17 203.52 213.86 185.25 238.08
Interest 0.87 0.63 0.64 0.64 0.26 0.66 0.68
Gross Profit 287.16 222.98 302.35 262.06 263.67 242.17 296.30
Depreciation 17.70 17.07 14.75 14.67 14.59 13.83 13.64
Taxation 93.58 69.50 103.88 86.78 86.86 79.66 118.37
Net Profit / Loss 175.88 136.41 183.72 160.61 162.22 148.68 220.34
Extra Ordinary Item 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Prior Year Adjustments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Capital 42.06 42.06 42.06 42.06 42.06 42.06 42.06
Equity Dividend Rate 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Agg.Of Non-Prom. Shares 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Agg.Of Non PromotoHolding(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EPS Before Extra Ordinary Items
Basic EPS 41.82 32.43 43.69 38.19 38.57 35.35 52.39
Diluted EPS 41.82 32.43 43.69 38.19 38.57 35.35 52.39
EPS After Extra Ordinary Items
Basic EPS 41.82 32.43 43.69 38.19 38.57 35.35 52.39
Diluted EPS 41.82 32.43 43.69 38.19 38.57 35.35 52.39
No Data Found !!
Rs in Cr Dec 2017 Mar 2017 Sep 2016 Dec 2016 Mar 2016 Sep 2015 Dec 2015
Sales 3,986.46 1,962.26 2,024.17 4,136.27 2,138.04 2,087.28 4,307.59
Other Income 243.88 126.88 117.00 277.51 114.68 113.82 221.89
Stock Adjustment -7.66 7.88 -15.54 -2.70 -53.20 50.50 -42.97
Raw Material 1,150.75 557.34 593.41 1,221.76 646.43 575.33 1,378.87
Power And Fuel 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Employee Expenses 458.03 210.28 247.75 504.98 265.34 241.00 431.29
Excise 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Admin And Selling Expenses 514.67 265.94 248.74 544.09 359.22 263.88 717.08
Research And Devlopment Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses Capitalised 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Expenses 883.33 447.74 435.59 905.50 469.79 445.64 930.01
Provisions Made 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Profit 833.49 384.76 448.69 838.16 394.03 442.88 730.08
Interest 2.78 1.50 1.28 2.28 0.37 1.35 0.74
Gross Profit 1,074.59 510.14 564.41 1,113.39 508.34 555.35 951.23
Depreciation 64.18 34.77 29.42 57.44 28.42 32.87 62.09
Taxation 353.74 163.08 190.66 368.67 167.39 202.16 305.54
Net Profit / Loss 656.67 312.29 344.33 687.28 312.53 376.37 583.60
Extra Ordinary Item 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Prior Year Adjustments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Capital 42.06 42.06 42.06 42.06 42.06 42.06 42.06
Equity Dividend Rate 700.00 0.00 0.00 0.00 0.00 0.00 550.00
Agg.Of Non-Prom. Shares 0.00 0.00 0.00 0.00 0.00 0.00 1.16
Agg.Of Non PromotoHolding(%) 0.00 0.00 0.00 0.00 0.00 0.00 27.54
EPS Before Extra Ordinary Items
Basic EPS 156.15 0.00 81.87 163.42 0.00 89.48 138.77
Diluted EPS 156.15 0.00 81.87 163.42 0.00 89.48 138.77
EPS After Extra Ordinary Items
Basic EPS 156.15 0.00 81.87 163.42 0.00 89.48 138.77
Diluted EPS 156.15 0.00 81.87 163.42 0.00 89.48 138.77

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for GlaxoSmithKline Consumer Healthcare Ltd. that will help you decide whether to buy, sell or hold GlaxoSmithKline Consumer Healthcare Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against GlaxoSmithKline Consumer Healthcare Ltd.